Protai

2 stories about Protai
Protai Founders

Protai adds $12 million to Seed round as it aims to build oncology drug discovery pipeline

15.03.23|CTech
The Israeli startup, which has built a proteomics AI-based platform that comprehensively maps the course of a disease on the protein level, aims to better predict which patients will respond to a given drug as well as discover novel drug targets that were missed by genomic approaches
Kirill Pevzner and Eran Seger Protai

Protai raises $8 million in Seed for its proteomics-based platform for drug discovery

05.01.22|James Spiro
The company has developed an end-to-end AI-based platform that can map the course of a disease on the protein level